122 related articles for article (PubMed ID: 698557)
21. HBV-associated DNA polymerase activity in plasmas from HBsAg carriers in Taiwan.--A preliminary report.
Lai LW; Hsu LC; Liu WT; Chen DS; Chen JY; Yang CS
Taiwan Yi Xue Hui Za Zhi; 1982 Aug; 81(8):1023-6. PubMed ID: 6960130
[No Abstract] [Full Text] [Related]
22. Relevance of HBe/anti-HBe system and DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis. A prospective study.
Marchesini G; Zoli M; Angiolini A; Feliciangeli G; Santoro A; Ferroni P; Zanetti AR
Nephron; 1981; 29(1-2):44-8. PubMed ID: 7329473
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.
Perrillo RP; Gelb L; Campbell C; Wellinghoff W; Ellis FR; Overby L; Aach RD
Gastroenterology; 1979 Jun; 76(6):1319-25. PubMed ID: 437428
[TBL] [Abstract][Full Text] [Related]
24. Antiviral treatment of chronic hepatitis B virus infection: infectious virus cannot be detected in patient serum after permanent responses to treatment.
Scullard GH; Greenberg HB; Smith JL; Gregory PB; Merigan TC; Robinson WS
Hepatology; 1982; 2(1):39-49. PubMed ID: 6172352
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B surface antigen/IgM complexes: relation to receptors for polymerized human serum albumin, hepatitis B virus (HBV) DNA polymerase activity and HBV markers.
Mora I; Carreño V; Porres JC; Gutiez J; Guio CH
Acta Virol; 1987 Mar; 31(2):116-25. PubMed ID: 2886020
[TBL] [Abstract][Full Text] [Related]
26. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
Scullard GH; Pollard RB; Smith JL; Sacks SL; Gregory PB; Robinson WS; Merigan TC
J Infect Dis; 1981 Jun; 143(6):772-83. PubMed ID: 6166691
[TBL] [Abstract][Full Text] [Related]
27. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
Smith CI; Kitchen LW; Scullard GH; Robinson WS; Gregory PB; Merigan TC
JAMA; 1982 Apr; 247(16):2261-5. PubMed ID: 6175774
[TBL] [Abstract][Full Text] [Related]
28. [Vidarabine treatment of chronic active hepatitis associated with hepatitis B virus multiplication. A randomized multicenter study].
Ouzan D; Degos F; Marcellin P; Linberg J; Chevallier M; Degott C; Bréchot C; Chossegros P; Weiss AM; Hirtz J
Gastroenterol Clin Biol; 1987; 11(8-9):568-73. PubMed ID: 3308617
[TBL] [Abstract][Full Text] [Related]
29. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
[TBL] [Abstract][Full Text] [Related]
30. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
[TBL] [Abstract][Full Text] [Related]
31. Differential activation of hepatitis B DNA polymerase by detergent and salt.
Hirschman SZ; Gerber M; Garfinkel E
J Med Virol; 1978; 2(1):61-76. PubMed ID: 681913
[TBL] [Abstract][Full Text] [Related]
32. [Markers of viral replication (HBeAg and DNA polymerase activity) in chronic uremia, HBsAg positive, hemodialysis patients].
Dentico P; Buongiorno R; Angarano G; Monno L; Coppola S; Laddago V; Spinelli A; Pastore G
Boll Soc Ital Biol Sper; 1980 Nov; 56(21):2193-9. PubMed ID: 7213481
[TBL] [Abstract][Full Text] [Related]
33. [Markers of type B viral hepatitis].
Brunello F; Emanuelli G; Camussi G
Minerva Med; 1979 Sep; 70(41):2791-800. PubMed ID: 386166
[TBL] [Abstract][Full Text] [Related]
34. Effects of suramin on in vitro HBsAg production by PLC/PRF/5 cells and hepatitis B virus DNA polymerase activity.
Kessler HA; Pottage JC; Trenholme GM; Benson CA; Levin S
AIDS Res; 1986 Feb; 2(1):63-72. PubMed ID: 2424468
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of chronic hepatitis patients with HBsAg, HBeAg and Dane particles associated DNA polymerase in serum.
Norkrans G; Nordenfelt E; Hermodsson S; Iwarson S
Scand J Infect Dis; 1980; 12(2):159-60. PubMed ID: 7375828
[TBL] [Abstract][Full Text] [Related]
36. Changes in hepatitis B virus DNA-polymerase activity in patients with chronic infection.
Alberti A; Pontisso P; Realdi G
J Med Virol; 1981; 8(4):223-9. PubMed ID: 7334359
[TBL] [Abstract][Full Text] [Related]
37. [Adenine arabinoside: hope in the treatment of chronic virus B hepatitis].
Guerre J; Gaudric M; Couturier D; Levy C
Presse Med; 1983 Mar; 12(12):743-6. PubMed ID: 6220311
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV.
Trépo C; Ouzan D; Fontanges T; Chevallier M; Chossegros P; Degos F; Chevallier P; Hantz O
J Hepatol; 1986; 3 Suppl 2():S97-105. PubMed ID: 2439581
[TBL] [Abstract][Full Text] [Related]
39. [Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B].
Zoulim F; Capel F; Berthillon P; Trépo C; Petit MA
Gastroenterol Clin Biol; 1995 Dec; 19(12):970-5. PubMed ID: 8729407
[TBL] [Abstract][Full Text] [Related]
40. Changes in hepatitis B virus DNA polymerase in relation to the outcome of acute hepatitis type B.
Alberti A; Diana S; Eddleston AL; Williams R
Gut; 1979 Mar; 20(3):190-5. PubMed ID: 437551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
